Tandem Diabetes Care (TNDM) Gross Margin Growth (3y) (2016 - 2026)
Analysis
Tandem Diabetes Care (TNDM) Gross Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 264.00 |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 104.00 |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | -89.00 |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 459.00 |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 8.00 |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -316.00 |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | 393.00 |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 73.00 |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 113.00 |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | 495.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 495.00 |
| Mar 31, 2026 | 638.00 |
| Dec 31, 2025 | 528.00 |
| Sep 30, 2025 | 283.00 |
| Jun 30, 2025 | 139.00 |
| Mar 31, 2025 | -127.00 |
| Dec 31, 2024 | 155.00 |
| Sep 30, 2024 | -277.00 |
| Jun 30, 2024 | -288.00 |
| Mar 31, 2024 | -257.00 |
| Dec 31, 2023 | -647.00 |
| Sep 30, 2023 | -449.00 |
| Jun 30, 2023 | 214.00 |
| Mar 31, 2023 | -238.00 |
| Dec 31, 2022 | -321.00 |
| Sep 30, 2022 | -249.00 |
| Jun 30, 2022 | -261.00 |
| Mar 31, 2022 | 125.00 |
| Dec 31, 2021 | -35.00 |
| Sep 30, 2021 | 675.00 |